bloXroute Labs, Inc. announced that it will issue 5,059,680 series B preferred shares at a price of $14.8231 per share for gross proceeds of $75,000,143 in funding on March 29, 2022. The shares will be convertible into common shares at a fixed conversion price of $14.8231 per share. The shares are non-redeemable.